Aubrey Rankin - Dec 3, 2021 Form 4 Insider Report for Revance Therapeutics, Inc. (RVNC)

Role
President, Innovation & Tech, Director
Signature
/s/ Dwight Moxie, Attorney-in-Fact
Stock symbol
RVNC
Transactions as of
Dec 3, 2021
Transactions value $
$432,876
Form type
4
Date filed
12/6/2021, 07:34 PM
Previous filing
Aug 17, 2021
Next filing
Mar 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Purchase $433K +30K +45.83% $14.43 95.5K Dec 3, 2021 Direct F1
holding RVNC Common Stock 154K Dec 3, 2021 The Rankin Irrevocable Trust F2
holding RVNC Common Stock 322K Dec 3, 2021 Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009 F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Table 1, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.33 to $14.50. Mr. Rankin undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2 These shares are held by The Rankin Irrevocable Trust. Mr. Rankin is a Trustee of the Rankin Irrevocable Trust.
F3 These shares are held by the Aubrey and Luanne Rankin Revocable Living Trust dated July 1, 2009. Mr. Rankin is a Trustee of this Trust.